-
Roche Pays $2.4 Billion For Rest Of Cancer Expert Foundation Medicine
Reuters | Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine, raising its bet on the U.S. genomic profiling group's ability to personalize cancer care.
Jun 19, 2018
-
Celgene’s LabAlert System Focuses On Scientific Workflow Efficiency, User Experience
Bio-IT World | Innovative mobile technology that quickly sends warnings and error notifications to users’ mobile devices won a Bio-IT World 2018 Best Practices Award. The Celgene Lab Instrument Mobile Alert (LabAlert) system integrates into the laboratory environment to generate, manage, and report real-time alerts from lab instruments to mobile devices.
Jun 18, 2018
-
Benchling Raises $14.5M From Benchmark To Advance Life Sciences Research
Bio-IT World Brief | Today Benchling announced it has closed $14.5M in Series B funding led by Benchmark, with participation from F-Prime Capital and returning investor Thrive Capital.
Jun 14, 2018


